Joanna Horobin

Companies

• Liquidia CorporationBoard member Mar 26, 2021 to now¹
• Kymera TherapeuticsBoard member Aug 20, 2020 to Jun 7, 2024²
• Vyant Bio, Inc.Board member Apr 1, 2021 to Jan 19, 2023³
• Liquidia Technologies (United States)Board member Sep 12, 2019 to Jun 23, 2020⁴
• Idera SoftwareSVP and Chief Medical Officer Dec 2, 2015 to Jul 11, 2019⁵
• Verastem OncologyChief Medical Officer Nov 2, 2012 to Jan 12, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• LLiquidia Corporation LQDA39,637 shares⁷$1.4M at $34.78Jun 16, 2026
• VBVyant Bio, Inc.23,123 shares⁸Jan 17, 2023
• KTKymera Therapeutics KYMR0 shares⁹Jun 7, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 16, 2026Granted 5,882 shares of Liquidia Corporation⁷
• Aug 19, 2025Sold 5,000 shares at $27.17 of Liquidia Corporation¹⁰
• Jun 17, 2025Granted 18,396 shares of Liquidia Corporation¹¹
• Jun 20, 2024Granted 20,359 shares of Liquidia Corporation¹²
• Jun 7, 2024Sold 6,313 shares at $33.11 of Kymera Therapeutics⁹
• Jun 7, 2024Sold 2,187 shares at $32.65 of Kymera Therapeutics⁹
• Jun 7, 2024Exercised options 8,500 shares at $2.08 of Kymera Therapeutics⁹
• Jan 17, 2023Granted 7,526 shares of Vyant Bio, Inc.⁸
• Oct 17, 2022Granted 14,285 shares of Vyant Bio, Inc.¹³
• Jul 18, 2022Granted 8,092 shares of Vyant Bio, Inc.¹⁴
• Apr 18, 2022Granted 6,796 shares of Vyant Bio, Inc.¹⁵
• Mar 30, 2022Granted 43,478 shares of Vyant Bio, Inc.¹⁶
• Jan 18, 2022Granted 5,343 shares at $1.31 of Vyant Bio, Inc.¹⁷